£84.46

It has never been this cheap. We have no record of a lower price.

£84 today · cheaper than every other day in the last 3 months

Springer Levodopa-Induced Dyskinesia in Parkinson's Disease

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days · 35 data points (no recent data)

Historical
Generating forecast…
£84.46 £80.24 £81.93 £83.62 £85.30 £86.99 £88.68 12 August 2026 20 August 2026 29 August 2026 06 September 2026 15 September 2026
View at Amazon ↗

Price data last checked 56 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 35 days • 1 price levels

Days at Price
35 days 0 9 18 26 35 £84 Days at Price

Price Analysis

Most common price: £84 (35 days, 100.0%)

Price range: £84 - £84

Price levels: 1 different prices over 35 days

Description

This book aims to provide a single reference source on levodopa-induced dyskinesias (LID) from ‘bench to bedside’. Initial chapters review the clinical features and phenomenology of LID with video examples; epidemiology and genetic risk factors for LID are covered as a background to understanding risk factors for developing LID. The following chapters cover the latest preclinical studies aiming to understand the pathophysiology of LID at the cellular, neurochemical, neurophysiological and circuitry level with detailed discussion of mechanisms and future directions to take the field forward; clinical studies from phase II to phase IV; on going RCTs in LID and evidence-based medicine reviews of treatment options. Levodopa-Induced Dyskinesia in Parkinson’s Disease is aimed at an international audience of movement disorder neurologists; neuroscientists; trainees and graduate and post-graduate students.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials
84% match

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials

Cambridge University Press

£94.61 22 Oct 2026
Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice
83% match

Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice

Elsevier

£137.99 21 Oct 2026
Handbook of Non-Motor Symptoms in Parkinson's Disease
83% match

Handbook of Non-Motor Symptoms in Parkinson's Disease

Springer

£39.77 24 Oct 2026
Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management
83% match

Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management

Cambridge University Press

£80.38 30 Oct 2026
Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)
82% match

Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)

Elsevier

£163.99 21 Oct 2026
Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)
82% match

Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)

Humana

£62.45 21 Oct 2026
Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive
82% match

Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive

Springer

£61.98 26 Oct 2026
Neuropsychiatric Disorders
82% match

Neuropsychiatric Disorders

Springer

£113.77 23 Oct 2026
Psychiatric and Cognitive Disorders in Parkinson's Disease (Psychiatry and Medicine)
82% match

Psychiatric and Cognitive Disorders in Parkinson's Disease (Psychiatry and Medicine)

Cambridge University Press

£117.47 03 Nov 2026
Psych Cog Disorders Parkinson Dis
82% match

Psych Cog Disorders Parkinson Dis

Cambridge University Press

£52.48 27 Oct 2026
Diagnosis and Treatment of Parkinson’s Disease ― State of the Art: 56 (Journal of Neural Transmission. Supplementa, 56)
81% match

Diagnosis and Treatment of Parkinson’s Disease ― State of the Art: 56 (Journal of Neural Transmission. Supplementa, 56)

Springer

£132.71 30 Aug 2026
Movement Disorders Curricula
81% match

Movement Disorders Curricula

Springer

£94.61 21 Oct 2026
Cognitive Impairment and Dementia in Parkinson's Disease
81% match

Cognitive Impairment and Dementia in Parkinson's Disease

Oxford University Press

£113.96 15 Sep 2026
Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)
81% match

Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)

Springer

£108.97 22 Oct 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
81% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£97.49 17 Oct 2026
Noves formes farmacèutiques i vies d'administració de levodopa: per al tractament de la malaltia de Parkinson
81% match

Noves formes farmacèutiques i vies d'administració de levodopa: per al tractament de la malaltia de Parkinson

VDM Verlag

£82.00 03 Nov 2026
Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)
81% match

Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)

Springer

£76.42 27 Oct 2026
Time to Prevent Parkinson's Disease
80% match

Time to Prevent Parkinson's Disease

£105.16 15 Sep 2026
Therapeutic Exercise for Parkinson's Disease and Related Disorders: A Comprehensive Clinical Strategy for Preventing and Reversing Neurodegeneration
80% match

Therapeutic Exercise for Parkinson's Disease and Related Disorders: A Comprehensive Clinical Strategy for Preventing and Reversing Neurodegeneration

Springer

£89.30 30 Oct 2026
Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)
80% match

Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)

Springer

£108.33 03 Nov 2026
Movement Disorders in Dementias
80% match

Movement Disorders in Dementias

Springer

£102.53 22 Oct 2026
Movement Disorders in Dementias
80% match

Movement Disorders in Dementias

Springer

£80.67 21 Oct 2026
Mechanisms and Emerging Therapies in Tremor Disorders (Contemporary Clinical Neuroscience)
80% match

Mechanisms and Emerging Therapies in Tremor Disorders (Contemporary Clinical Neuroscience)

Springer

£179.99 15 Sep 2026
Movement Disorders: Genetics and Models
80% match

Movement Disorders: Genetics and Models

Elsevier

£185.00 30 Oct 2026